Cytoki Pharma
Phase 2Cytoki Pharma is a biotechnology company developing a portfolio of IL-22-based drugs as a new treatment paradigm for serious diseases involving epithelial injury.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Funding information not available
About
Cytoki Pharma is a biotechnology company developing a portfolio of IL-22-based drugs as a new treatment paradigm for serious diseases involving epithelial injury.
Biologics